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The hepatitis delta virus (HDV) is an RNA virus that depends on DNA-dependent RNA polymerase (RNAP) for its transcription and
replication. While it is generally accepted that RNAP II is involved in HDV replication, its interaction with HDV RNA requires confirmation. A
monoclonal antibody specific to the carboxy terminal domain of the largest subunit of RNAP II was used to establish the association of RNAP II
with both polarities of HDV RNA in HeLa cells. Co-immunoprecipitations using HeLa nuclear extract revealed that RNAP II interacts with HDV-
derived RNAs at sites located within the terminal stem–loop domains of both polarities of HDV RNA. Analysis of these regions revealed a strong
selection to maintain a rod-like conformation and demonstrated several conserved features. These results provide the first direct evidence of an
association between human RNAP II and HDV RNA and suggest two transcription start sites on both polarities of HDV RNA.
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The hepatitis delta virus (HDV) is a subviral satellite virus of
the hepatitis B virus (HBV) and is composed of a single-
stranded, circular RNA molecule of approximately 1700
nucleotides (Chen et al., 1986). Its genome forms an
unbranched, rod-shaped structure with a high proportion of
canonical base pairing, contains two complementary ribozyme
motifs (i.e. delta ribozymes), and has a single open reading
frame producing two viral proteins (HDAgs; Fig. 1; Taylor,
2006). These two proteins are identical in sequence, except that
the large HDAg (HDAg-L) contains 19 additional amino acids
at its C-terminus resulting from RNA editing of the termination
codon of the small HDAg (HDAg-S) gene (Casey et al., 1992;
Wang et al., 1992; Weiner et al., 1988; Xia et al., 1990). Each
protein has a distinct function: HDAg-S (195 amino acids) is
essential for HDVaccumulation, while the HDAg-L (214 amino
acids) is required for virion assembly and is reported to be a
dominant negative inhibitor of replication (Chang et al., 1991;
Kuo et al., 1989; Ryu et al., 1992).⁎ Corresponding author. Fax: +1 613 562 5452.
E-mail address: mpelchat@uottawa.ca (M. Pelchat).
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doi:10.1016/j.virol.2006.08.010Although HDV requires HBV for encapsidation and
transmission, it relies entirely on its host for replication. HDV
replicates through a symmetrical rolling circle mechanism that
involves only RNA intermediates (Chen et al., 1986; Kuo et al.,
1988a,b; Lai, 2005; Taylor, 2006). Replication of the genomic
circular monomer produces linear, multimeric strands which are
subsequently self-cleaved and ligated, resulting in antigenomic
polarity circular monomers. This process is repeated to generate
the genomic RNA, which is found at a greater intracellular
abundance than the antigenomic species (Chen et al., 1986).
Because HDV does not encode its own replicase, host DNA-
dependent RNA polymerases (RNAPs) are considered to be
involved in the replication and transcription of HDV RNA (Lai,
2005).
Many studies using cultured cells and cell extracts have
suggested that RNAP II might be responsible for HDV
replication based on the sensitivity of the accumulation of
HDVmRNA and processed unit-length genomic HDV RNAs to
low levels of α-amanitin, a mycotoxin that inhibits DNA-
dependent RNA synthesis by RNAP II (de Mercoyrol et al.,
1989; Filipovska and Konarska, 2000; Fu and Taylor, 1993;
Macnaughton et al., 1991). This hypothesis was substantiated
by experiments using cells containing an α-amanitin-resistant
Fig. 1. Schematic representation of the HDV RNA genome. The structure illustrates the superimposed features of both the genomic and antigenomic HDV polarities.
The genome is depicted in its circular, unbranched rod-like conformation. The location of the genomic and antigenomic ribozymes and the open reading frame for
HDAg are indicated. The position of the primers used to generate the R199G RNA molecule is indicated. The numbering is in accordance with Kuo et al. (1988a).
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transcription inhibition by α-aminitin (Modahl et al., 2000).
RNAP II is furthermore speculated to be involved in the
transcription of the HDAg mRNA because, in vivo, this mRNA
was shown to be post-transcriptionally processed with a 5′-cap
and a 3′-poly(A) tail, which are typical features of transcripts
generated by RNAP II (Gudima et al., 2000; Nie et al., 2004).
Additionally, in in vitro transcription assays using nuclear
extract (NE) from HeLa cells and RNA derived from the left
terminal stem–loop domain of HDV antigenomic RNA,
synthesis of the complementary strand was possible (Filipovska
and Konarska, 2000). Accumulation of this RNA product was
highly sensitive to α-amanitin. This sensitivity was partially
abrogated in experiments conducted in NE from cells contain-
ing an α-amanitin-resistant allele of the largest subunit of
RNAP II, suggesting the involvement of RNAP II in this
reaction. Interestingly, the transcription did not proceed by de
novo initiation, but rather by cleavage of the RNA template
followed by extension of the new 3′-end, generating a chimeric
template/transcript product.
Conversely, the accumulation of the antigenomic RNA
species has been shown to be resistant to a higher dose of
α-amanitin, suggesting the involvement of another yet unknown
RNAP in the life cycle of HDV (Macnaughton et al., 2002;
Modahl et al., 2000). It has been hypothesized that RNAP I or an
RNAP I-like polymerase might be involved in HDV replication
because antigenomic HDVRNAwas shown to accumulate in the
nucleolus and its synthesis is associated with the RNAP I-
specific transcription factor SL1 (Li et al., 2006).
Because general host DNA-directed RNAP II transcription
is inhibited at relatively low doses of α-amanitin (de Mercoyrol
et al., 1989), the observed inhibition of HDV RNA accumula-
tion in the presence of this transcription inhibitor might be an
indirect rather than a direct effect. It is difficult to differentiate
between specific inhibition of HDV replication and non-specific
toxic effects on host cells or the need for some additional host
DNA-directed RNAP II transcripts. In addition, because the
enzymes involved in HDV transcription/replication are host
DNA-dependent RNAPs coerced to use an RNA template,
sensitivity of RNAP II, or any other host RNAP(s), to α-
amanitin might be affected by the nature of the template (i.e.
RNA versus DNA). Such a phenomenon was reported for
actinomycin D (Meienhofer and Atherton, 1973; Pelchat and
Perreault, 2004) and was recently observed with tagetitoxin
(Pelchat et al., 2001), a potent inhibitor of bacterial RNAP and
nuclear DNA-dependent RNAP III (Mathews and Durbin,
1994). Like α-amanitin, tagetitoxin is believed to inhibit theelongation phase of RNA synthesis by interacting with the
ternary complex that contains the RNAP, the template, and the
nascent RNA (Mathews and Durbin, 1994; Gong et al., 2004).
RNAP inhibitors must thus be usedwith caution when utilized as
a means of identifying an RNAP involved in RNA-dependent
transcription.
Although HDV replication has been shown to be sensitive to
low concentrations of α-amanitin, suggesting RNAP II activity,
no direct interaction between RNAP II and HDV RNA has been
reported. The present study was undertaken (i) to confirm the
association of RNAP II with HDV RNA, and (ii) to identify the
regions on the HDV RNA genome responsible for this
interaction. To this end, we took advantage of an antibody
raised against the carboxy terminal domain (CTD) of RNAP II
to clarify the interaction of RNAP II with HDV RNA by directly
examining their association in vivo within HeLa cells. We
identified the regions involved in this interaction by co-
immunoprecipitating various HDV-derived RNAs with RNAP
II using HeLa nuclear extract (NE) and the anti-RNAP II
antibody. Then, we used covariation analysis on natural variants
to analyze the conserved nucleotides and structural motifs of the
interaction sites of RNAP II on HDV RNA. Our analyses
support a role for the human RNAP II in the life cycle of HDV
by demonstrating its association with HDV RNA in vivo and
with the terminal stem–loop domains of both polarities of HDV
RNA in vitro.
Results
RNAP II interacts with HDV RNA within HeLa cells
To establish the direct interaction between RNAP II and
HDV RNA in vivo, we immunoprecipitated RNAP II from
HeLa cells containing both polarities of HDV RNA and tested
for the presence of viral RNA in the immunoprecipitated
samples. To this end, we used the monoclonal antibody (mAb)
8WG16 which was raised against wheat germ RNAP II and
found to recognize epitopes conserved among the CTDs of
RNAP IIs derived from a variety of different eukaryotes
(Thompson et al., 1989). When this commonly used antibody
is tested against HeLa NE proteins, only one band
corresponding to the largest subunit of RNAP II is revealed
by Western blot. To obtain cells harboring both polarities of
HDV RNA, HeLa cells were transiently transfected with a
dimeric HDV transcript of genomic polarity and a eukaryotic
expression vector overexpressing HDAg-S, which has been found
to be essential for HDV RNA accumulation (Kuo et al., 1989).
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RNA–protein complexes cross-linked with formaldehyde in
vivo using the ribonucleoprotein immunoprecipitation (RIP)
assay developed by Niranjanakumari et al. (2002). Following
immunoprecipitation and high-stringency washes to ensure the
specificity of the binding, the cross-links were reversed by
heating the samples. Recovered nucleic acids were then
extracted and subjected to RT-PCR. For this step, we used
primers for a cDNA fragment corresponding to what we refer to
as the right-terminal stem–loop domain of HDV (Fig. 1,
R199GFW and R199GREV). In addition to the HDV sequence
(nucleotides 1541 to 61), the 232 bp cDNA fragment generated
after RT-PCR included a promoter for the T7 RNAP and
recognition sites for restriction enzymes. When we used the
8WG16 mAb to immunoprecipitate the sample, cDNA frag-
ments corresponding to both polarities of R199 were detected
(Fig. 2, 8WG16 lanes). Cloning and subsequent sequence
analysis confirmed the identity of the HDV-derived cDNA
fragments. These cDNA fragments were detected neither in the
control reactions lacking antibody nor in the goat anti-mouse
IgG mAb control reactions (Fig. 2), indicating that cDNAs
obtained from this assay were specific to the samples
immunoprecipitated with the 8WG16 mAb. Moreover, these
fragments were also absent from samples that were not subjected
to the cross-linking reaction prior to co-immunoprecipitation
(Fig. 2, No-XL 8WG16 lanes). To ascertain that the association
with the RNAP II complex is specific for HDV RNA, RT-PCR
was also performed on an abundant cellular RNA (β-actin
mRNA). As shown in Fig. 2B, although the β-actin cDNA
fragment was easily amplified from crude extract from HeLa
cells, this fragment was not detected in the various immunopre-
cipitation reactions performed above. Overall, the presence of
HDV RNA fragments in the cross-linked, immunoprecipitated
samples provides evidence that formaldehyde covalently cross-Fig. 2. Association of RNAP II with HDV RNAwithin HeLa cells. HeLa cells trans
immunoprecipitation using the 8WG16 mAb, no antibody, or the control goat anti-m
mAb is also presented. (A) Association of RNA with both polarities of HDV RNA
transcribed HDV RNA of genomic and antigenomic polarity, respectively. AG and
antigenomic or genomic HDV RNA corresponding to the R199 region. (B) Contr
immunoprecipitations for HDV RNAs. The co-immunoprecipitated samples are as de
HDV RNA before and after co-immunoprecipitation with the 8WG16 mAb. Lanes M
GelPilot Mid Range DNA ladder (Qiagen).links the largest subunit of RNAP II or a complex containing
RNAP II to HDV RNA in HeLa cells. To corroborate this
finding, we used a pair of primers corresponding to the other
terminal stem–loop region of the HDV RNA genome (i.e. L213,
nucleotides 687 to 900); identical results were obtained (data not
shown).
The primers used in the RT reactions were designed to
differentiate between both polarities of HDV RNA. Specifi-
cally, primers corresponding to sequences of the genomic (i.e.
R199GFW) and antigenomic (i.e. R199GREV) strand of HDV
RNA were only able to reverse transcribe from either the
antigenomic or the genomic polarity of HDV RNA, respectively
(Fig. 2, HDVG and HDVAG RNA lanes). Since both polarities
of HDV RNAwere recovered when the cross-linked sample was
immunoprecipitated with the 8WG16 mAb, we conclude that
both polarities of HDV RNA associate with RNAP II within
HeLa cells, which directly establishes the association of the
human RNAP II with HDV RNA and strongly suggests its
involvement in the synthesis of both strands of HDV RNA.
Although the RT-PCR reactions were not quantitative, the
intensity of the bands corresponding to both polarities of HDV
RNA co-immunoprecipitated using the 8WG16 mAb was
similar. Because it has been established that genomic HDV
RNA accumulates more than antigenomic HDV RNA in
infected cells (Chen et al., 1986), our results suggest a more
efficient binding of RNAP II to the antigenomic polarity of
HDV RNA. To confirm the preferential interaction of RNAP II
with this polarity, semi-quantitative RT-PCR was performed on
RNA samples taken either before or after co-immunoprecipita-
tion with the 8WG16 mAb. Because no human RNA is
expected to co-immunoprecipitate with RNAP II, it was not
possible to normalize the different samples using an internal
RNA control. To circumvent this difficulty, amplification
curves were performed and used to determine the number offected with HDV RNAwere used for the preparation of cross-linked lysates for
ouse IgG mAb. Non-cross-linked lysate immunoprecipitated using the 8WG16
. HDVG and HDVAG RNA lanes are RT-PCR product controls using in vitro
G lanes contain RT reactions performed using primers complementary to either
ol RT-PCR using the β-actin cDNA to demonstrate the specificity of the co-
scribed above. (C) Semi-quantitative RT-PCR amplifications of both polarities of
contain DNA ladders: panels A and C, PhiX174 digested with HaeIII; panels B,
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phase of amplification. Then, the intensities of the cDNA bands
corresponding to both polarities of HDV RNA were compared
within each sample. Prior to co-immunoprecipitation, we found
a genomic:antigenomic HDV RNA ratio of 1.99:1. Although
less than reported using infected liver cells, this value is in
conformity with a greater intracellular abundance of genomic
HDV RNA when compared to antigenomic HDV RNA (Chen
et al., 1986). By performing a similar calculation for the sample
co-immunoprecipitated with the 8WG16 mAb, we found that
the genomic:antigenomic HDV RNA ratio shifted to 1:1.56. As
a result, under our conditions, antigenomic HDV RNA was
enriched 3.1-fold after co-immunoprecipitation with the
8WG16 mAb. This enrichment indicates a preferential
interaction of RNAP II with antigenomic HDV RNA.
RNAP II interacts with the terminal stem–loop domains of both
polarities of HDV RNA in HeLa NE
The previous experiments provide evidence of the association
of RNAP II with both the genomic and antigenomic HDVRNAs
within HeLa cells. To determine the regions of the HDV RNA
genome responsible for this interaction, we investigated the
association of RNAP II with variousHDV-derivedRNAs in vitro
using HeLa NE. As an initial step, both polarities of the HDV
RNA genome were arbitrarily divided in three domains: 213 nt
RNAs corresponding to what we refer to as the left terminal
stem–loop (L213; nt 687 to 900), RNAs corresponding to the
double-stranded central region (CENTR; nt 681 to 54 and nt 900
to 1540), and 199 nt RNAs corresponding to the right terminal
stem–loop (R199; nt 1540 to 60). To guarantee that both RNA
molecules forming the CENTR RNAs annealed, both strands
were mixed, heated, slowly cooled, and tested for double-strand
formation. Electrophoresis on a native acrylamide gel confirmed
that most of the RNA molecules forming the CENTR RNAs
annealed under our conditions (data not shown). The various
radiolabeled HDV-derived RNAs were allowed to form RNA–
protein complexes with HeLa NE proteins. The 8WG16 mAb
was then added, the samples were immunoprecipitated using
protein-G agarose beads, and the co-immunoprecipitated com-
plexes were then subjected to denaturing gel electophoresis.
A typical gel using a radiolabeled RNA corresponding to the
right terminal stem–loop domain of the genomic polarity of
HDV RNA (i.e. R199G) is shown in Fig. 3A. Under our
conditions, a band corresponding to the radiolabeled RNAwas
detected when the sample was immunoprecipitated using the
8WG16 mAb in the presence of HeLa NE. This band was not
detected in the absence of NE or when the 8WG16 mAb was
replaced with the anti-mouse IgG mAb, indicating that the
signal observed was not the result of non-specific binding of
R199G to the protein-G agarose beads or to the 8WG16 mAb.
To ensure the specificity of the interaction, various RNA
competitors were tested. When an excess of unlabeled
homologous competitor was used, the intensity of the band
corresponding to the radiolabeled R199G was considerably
diminished. When poly-A RNAwas used as an unrelated RNA
competitor, no significant decrease in the co-immunoprecipita-tion of the radiolabeled R199G was observed. When acting on a
DNA promoter, RNAP II binds to double-stranded nucleic acid.
To verify that the observed association between RNAP II and
R199G was not caused by non-specific affinity for double-
stranded RNA, a small RNA hairpin (Fig. 3C, P11.60) derived
from the peach latent mosaic viroid (PLMVd) that acts as an
RNA promoter for the Escherichia coli RNAP (Pelchat et al.,
2002) was used as a competitor. The interaction between RNAP
II and R199G was not significantly decreased by addition of an
excess amount of P11.60. Taken together, these observations
demonstrate that RNAP II interacts specifically with R199G
within HeLa NE.
The interaction of RNAP II with the various regions of both
genomic and antigenomic HDV RNA iS summarized in Fig.
3B. Because several RNA molecules were tested, only the lanes
corresponding to the amount of RNA used and co-immunopre-
cipitation reactions in the presence of the non-specific RNA
competitor P11.60 with either the absence (−NE) or the
presence (+NE) of HeLa NE are presented. Under our
conditions, both polarities of the complete HDV RNA genome
co-immunoprecipitated specifically using the 8WG16 mAb
(Fig. 3B, HDVG and HDVAG). When the band intensities of
the co-immunoprecipitated RNAs were normalized using the
amount of radiolabeled RNA used, the antigenomic HDV RNA
(HDVAG) was found to be co-immunoprecipitated 1.9-fold
more efficiently than the genomic HDV RNA (HDVG). These
results are in agreement with our previous observations using
cross-linked lysates and indicate that RNAP II interacts more
efficiently with the antigenomic polarity of HDV RNA.
Next, the various HDV-derived RNAs corresponding to the
three arbitrary domains of both polarities were tested to
determine the regions on the HDV RNA genome responsible
for RNAP II interaction. Radioactive bands corresponding to
the stem–loop domains of both polarities of HDV RNA (i.e.
R199G, R199AG, L213G, and L213AG) were detected,
whereas bands corresponding to the central regions of both
polarities of HDV RNA (i.e. CENTRG and CENTRAG) were
not. These results indicate that RNAP II interacting sites are
located predominantly between nt 1540 to 60 and nt 687 to 900
on both polarities of the HDV RNA genome.
To further refine the regions interacting with RNAP II,
smaller HDV-derived transcripts were synthesized and were
used in the co-immunoprecipitation reactions. Specifically, R38
and L48, which correspond to 38 and 48 nt RNAs located at the
tip of the right and the left hairpin domains, respectively, were
tested for RNAP II interaction. Using the same co-immunopre-
cipitation conditions as above, we found that both polarities of
R38 and L48 were able to co-immunoprecipitate using the
8WG16 mAb (Fig. 3C), indicating that the terminal stem–loop
domains of both polarities of HDV RNA can be reduced to
smaller hairpins without significantly affecting their interaction
with RNAP II. As an additional negative control, P11.60 was
tested directly in the co-immunoprecipitation reactions. The
small PLMVd-derived RNA hairpin did not co-immunopreci-
pitate with RNAP II when using the 8WG16 mAb (Fig. 3C),
which further supports the specificity of the co-immunopreci-
pitation experiments. Because RNAP II complexes are
Fig. 3. Interaction of RNAP II with HDV-derived RNAs. (A) Co-immunoprecipitation of radiolabeled R199G with RNAP II in HeLa NE. 20-fold excess non-
radioactive R199G, poly-A RNA, or P11.60 (Pelchat et al., 2002) was used in competition experiments. (B) Interaction of RNAP II with various HDV-derived RNAs.
(C) Interaction of RNAP II with the extremities of the rod-like HDV secondary structure of both polarities. (D) Interaction of RNAP II with mutants affecting the
secondary structure and the purine/pyrimidine polarization. The numbering is in accordance with Kuo et al. (1988a). One tenth of the RNAs used for each co-
immunoprecipitation are used as markers. The co-immunoprecipitations presented in panels B – D were performed in the presence of a 20-fold excess P11.60, as a
non-specific RNA competitor.
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2002), we cannot conclude that the binding of the RNAP II core
enzyme to the various RNA molecules is direct. Also, we
cannot exclude the possibility that other RNAPs might be able
to recognize these RNA fragments. However, these results
provide direct evidence that a complex containing the CTD of
the largest subunit of RNAP II interacts specifically with the
terminal stem–loop domains of both polarities of HDV RNA in
HeLa NE.
Sequence and secondary structure analysis of the terminal
stem–loop domains of both polarities of HDV RNA
To interact with HDV RNA, RNAP II must recognize
specific features (i.e. sequences and/or secondary structures) on
both polarities of the terminal stem–loop domains. We have
taken advantage of the large number of known nucleotidesequences of in vivo selected variants to identify the features of
terminal stem–loop domains of HDV RNA by studying
positions of covariation and nucleotide conservation.
We collected the sequences corresponding to R38 and L48
from a total of 81 variants representing the various HDV
genotypes indexed in the Subviral RNA Database (Rocheleau
and Pelchat, 2006). First, we aligned all the RNA sequences
using the Clustal software (Thompson et al., 1994), which
generated a tree showing the sequence differences between
HDV genotypes. Due to the imperfect alignment of the analyzed
regions among the different HDV sequences, we applied
alignments to smaller data sets according to HDV genotypes
because of their lower degree of heterogeneity. For each of these
genotypes, the consensus features of the RNA secondary
structures generated by analysis of base-pair covariation were
determined. Finally, we combined alignments by insertion of
gaps so that homologous motifs (i.e. secondary structures) were
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alignment, the most thermodynamically stable secondary
structure was predicted and re-adjusted based on the base-pair
covariation data. Sequence conservation and the resulting
consensus RNA secondary structures for both polarities of
R38 and L48 are summarized in Fig. 4 together with the fully
conserved nucleotides (red nucleotides) and the location of the
base-pairs predicted by the covariation analysis (blue circles).
Despite heterogeneity among the different sequences and
genotypes, base-pair covariation analysis indicates a strong
selective pressure to maintain the rod-like conformation of
these regions in which most of the base-pairs can be predicted.
A few nucleotides within this region are conserved across all
the HDV sequences examined (Fig. 4, red nucleotides).
Considering the degree of nucleotide divergence in the
adjacent nucleotides, the observed conservation suggests a
functional role for the conserved nucleotides. Strikingly, a
short double-stranded stem (CUC/GAG) was found to be
exceptionally conserved (Fig. 4B, yellow box). In fact, most of
the nucleotides comprising this short CUC/GAG stem are
completely conserved in all the analyzed variants and the other
positions exhibit only minor variations. Notably, we observed
a strong polarization in the purine/pyrimidine content near the
tip of the rod up to the end of the CUC/GAG stem in all the
sequences analyzed. A region of 12 nt upstream of the terminal
loop of R38G and R38AG exhibits an average of 91.0±1.0%
pyrimidine content which is matched by a region on theFig. 4. Primary sequence conservation and proposed secondary structure of R38G/AG
(B) derived from the analysis of the alignment of 81 HDV natural variants are presente
ovals), and the conserved CUC/GAG motifs (yellow) are indicated. IUPAC 1-letter
structures showing less than 95% conservation.opposite strand containing almost exclusively purines (Fig.
4B). In the case of L48G and L48AG, the sequence upstream
of the loop contains 86.7±5.9% pyrimidines which is matched
by a region on the opposite strand having 82.0±5.8% purines
(Fig. 4B).
The secondary structure and the polarization in the purine/
pyrimidine content near the tip of the rod are required for
RNAP II interaction
Sequence analysis of natural HDV variants suggests that
the maintenance of the rod-like conformation and the
polarization in the purine/pyrimidine content near the tip of
the rod of both polarities of HDV RNA might be required for
RNAP II interaction. We therefore introduced substitutions to
R38G and L48AG aimed at destabilizing either of these
conserved features. First, the involvement of the purine-rich
segments located downstream of the terminal loops was
investigated. R38GPY and L48AGPY are derivative RNAs in
which the purine-rich segments were mutated to the
pyrimidine-rich sequences located on their respective upper
strands. Upon co-immunoprecipitation using the 8WG16
mAb, no significant association of RNAP II with either
R38GPY or L48AGPY was detected (Fig. 3D). Similar results
were obtained when R38GPU and L48AGPU, two derivative
RNAs in which the pyrimidine-rich segments located upstream
of the terminal loops were mutated to purine-rich sequences,and L48G/AG. The nucleotide motif (A) and the consensus secondary structure
d. Completely conserved nucleotides (red), observed base-pair covariation (blue
code abbreviations are used for the identity of the nucleotides on the secondary
74 V.S. Greco-Stewart et al. / Virology 357 (2007) 68–78were used. Specifically, no co-immunoprecipitation of either
R3G8PU or L48AGPU with RNAP II was detected (Fig. 3D).
Because the mutations found in these four mutants also result
in the disruption of their predicted rod-like structures, the
absence of RNAP II interaction with these RNAs could be the
result of the loss of their rod-like conformation. R38GSW and
L48AGSW, which contain compensatory mutations that restore
the predicted secondary structure of these hairpins, were
therefore synthesized and tested for association with RNAP
II. No complex formation was detected when using either of
these “flip” mutants (Fig. 3D). Taken together, these results are
in accordance with the sequence analysis of natural HDV
variants and indicate that the association of RNAP II with these
regions is dependent on the conformation and on the
polarization in the purine/pyrimidine content near the tip of
the rod.
Discussion
The mechanism of RNA synthesis is highly conserved and
can be roughly divided into three distinct phases: initiation,
elongation, and termination. For initiation to occur, RNAPs
search for and bind to promoter sequences to form a “closed
complex”; thus, association of RNAP II would indicate sites of
transcription (Smale and Kadonaga, 2003). Here, we have used
an antibody raised against the CTD of RNAP II to clarify RNAP
II interaction with HDV RNA by studying the first step of the
transcription process (i.e. promoter recognition). This approach
was used to directly demonstrate specific RNAP II interaction
with HDV RNA, both in vivo within HeLa cells and in vitro
using HeLa NE. Using various HDV-derived RNAs with HeLa
NE proteins, we have shown that specific RNAP II interaction
occurs in vitro predominantly via small domains located at the
extremities of both polarities of the rod-like secondary structure
of the HDV RNA genome, and that RNAP II might bind more
efficiently to the antigenomic polarity of HDV RNA.
It is possible that the observed interaction of RNAP II with
these regions might not lead to transcription initiation. When
binding to a DNA promoter, the RNAP II found within an
initiation site is hypophosphorylated at its C-terminal domain
(CTD) and is distinct from the elongating or terminating forms
of the enzyme that are hyperphosphorylated (Hahn, 2004; Sims
et al., 2004). In this study, we have used the 8WG16 mAb,
which specifically recognizes the unphosphorylated RNAP II
CTD (Patturajan et al., 1998); the extremities of both polarities
of HDV RNA are thus likely to be sites of pre-initiation
complex formation (i.e. active promoters; Thompson et al.,
1989; Smale and Kadonaga, 2003). Moreover, most of these
interaction sites are in agreement with previous reports.
The 5′-end of HDAg mRNA corresponds to an initiation site
located within R38G (Gudima et al., 2000). It is thus likely that
the right terminal stem–loop domain contains an RNA promoter
recognized by RNAP II. RNA fragments similar to both R199G
and L213AG were reported to be able to initiate polymerization
in vitro using HDV-derived RNAs and HeLa NE (Beard et al.,
1996; Filipovska and Konarska, 2000). Interestingly, transcrip-
tion from the RNA template similar to L213AG did not proceedby de novo initiation, but rather by cleavage of the RNA
template, followed by extension of the new 3′-end, generating a
chimeric template/transcript product (Filipovska and Konarska,
2000). An RNA fragment similar to L213G was also able to
generate a specific product in this system, despite the authors'
claim that the signal detected did not correspond to their typical
chimeric template/transcript product (Filipovska and Konarska,
2000). Here, we have shown that the right terminal stem–loop
region of antigenomic HDV RNA (i.e. R199AG) can also
interact with RNAP II and we have demonstrated that these four
RNA regions can be reduced significantly in length without
affecting RNAP II interaction. In summary, our results suggest
the involvement of RNAP II in the synthesis of both genomic
and antigenomic HDV RNAs. In addition, because RNAP II
interacts with the extremities of both polarities of the HDV
RNA genome, our data suggest the existence of two transcrip-
tion/replication start sites for both genomic and antigenomic
HDV RNAs. Moreover, it is possible that other RNAP(s) are
involved in HDV transcription/replication, given that only the
8WG16 mAb was tested.
The RNA fragments interacting with RNAP II were further
investigated by taking advantage of a large number of natural
HDV variants. Analysis of base-pair covariation indicated that
although changes in the primary sequence of these segments
might be tolerated, their respective secondary structures are
most likely critical for HDV replication/accumulation. The
conserved features of the two extremities of the rod-shaped
HDV RNA are very similar. Our analysis revealed a highly
ordered RNA secondary structure that is comprised of regions
of double-stranded RNA with a conserved CUC/GAG triple
base-pair motif and one strand of pyrimidines upstream of a 3–
8 nt terminal loop followed by a complementary strand of
purines. Because these features are found near all the terminal
loops of HDV RNA which were shown to interact with RNAP
II, it is tempting to suggest the involvement of these features in
RNAP II binding. Accordingly, mutagenesis of R38G and
L48AG, affecting the conformation and the polarization in the
purine/pyrimidine content near the tip of the rod, indicated that
the interaction of RNAP II with these regions is dependent on
these features.
Previous studies have reported extensive mutagenesis on the
extremities of the rod-like structure of HDV RNA and have
observed their effects on HDV RNA accumulation in vivo
(Beard et al., 1996; Gudima et al., 1999, 2006;Wang et al., 1997;
Wu et al., 1997). Fig. 5 presents a summary of these published
results. For the right terminal extremities, variation of the
terminal loop sequence and size had no effect on HDV RNA
accumulation (Gudima et al., 1999; Wu et al., 1997). In contrast,
disruption of the overall rod-like conformation of this region or
even small changes in the terminal stem had major effects on
accumulation of HDV RNA (Beard et al., 1996; Gudima et al.,
1999; Wu et al., 1997). In addition, HDV RNA accumulation
was found to be sensitive to the size of the 3 nt external bulge,
which includes the putative mRNA initiation site (Gudima et al.,
1999). Our analysis indicates that this bulge can be on either side
of the stem–loop structures and RNAP II interaction still occurs
(compare R38R/R38AG). However, correct positioning of this
Fig. 5. Summary of published mutagenesis results on the extremities of the rod-like structure of HDV RNA. The mutations and the resulting consequences on HDV
RNA accumulation were taken from (a) Beard et al., 1996, (b) Wu et al., 1997, (c) Wang et al., 1997, and (d) Gudima et al., 1999. Reported mutagenesis on either the
right- or the left-terminal extremities of the rod-like secondary structure of the HDV RNA are presented in panels A or B, respectively.
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HDAg mRNA synthesis. Noteworthy, a “flip” mutant in the
terminal stem was found to greatly affect HDV RNA
accumulation (Wu et al., 1997) in complete agreement with
our results. The association of RNAP II with this region and
initiation of transcription are thus dependent on the conforma-
tion and on the polarization in the purine/pyrimidine content
near the tip of the rod.
Conversely, the left-terminal region was found to be highly
tolerant to nucleotide changes within the loop and to
insertions as well as deletions in the adjacent stem region
(Wu et al., 1997). Only the removal of large segments or the
insertion of various non-HDV sequences in the conserved
CUC/GAG motifs resulted in loss of accumulation of HDV
RNA (Gudima et al., 2006; Wang et al., 1997). Interestingly,
most genomes containing large inserts lost their inserted
sequences suggesting the involvement of this region in HDV
RNA replication (Gudima et al., 2006). The divergence of
these reports with our results might be explained by the likely
involvement of another RNAP, such as RNAP I. Moreover,
because RNAP II was found to be associated with the stem–
loop region of both polarities of HDV RNA, suggesting at
least two replication start sites for each polarity of HDV
RNA, complementation of replication impaired mutants of the
left-terminal stem–loop structure might occur. Since the right
extremity contains sequences required for HDAg mRNA
transcription, such complementation might not occur, causing
the right terminal stem–loop region to be more sensitive to
mutation.We cannot exclude the possibility that the conserved features
of the HDV extremities might also be linked to activities
unrelated to RNAP II binding, such as RNA stabilization, RNA
transportation, or RNA encapsidation. For example, these
polypyrimidine/polypurine tracts could serve as binding sites
for other RNA-binding proteins. Typical representatives of
these types of proteins are the polypyrimidine tract-binding
(PTB) proteins and the heterogeneous nuclear ribonucleopro-
teins (hnRNPs), which, in uninfected cells, are involved in a
variety of processes, such as pre-mRNA splicing in the nucleus
(Garcia-Blanco et al., 1989; Swanson and Dreyfuss, 1988).
However, we recently reported the finding that the polypyr-
imidine tract-binding protein-associated splicing factor (PSF) is
also able to bind specifically to both polarities of HDV through
the terminal stem–loop domains of the rod-like structure
(Greco-Stewart et al., in press). Because PSF is known to
bind to the CTD of RNAP II (Emili et al., 2002) and PSF
binding sites correlate with the locations on the HDV RNA
genome found to be associated with RNAP II, it is tempting to
suggest that by interacting with both an HDV RNA promoter
and RNAP II, PSF or another polypyrimidine/polypurine tract-
binding protein might provide docking sites or assist RNAP(s)
in the formation of pre-initiation complexes. The co-immuno-
precipitation assay we used in this study will be a perfect tool in
determining the content of the RNAP II complex interacting
with HDV RNA and the contribution of additional trans-acting
host factors in RNA promoter recognition by RNAP II. For
instance, although HDAg-S was demonstrated to be essential
for HDV accumulation (Kuo et al., 1989), our results indicate
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with HDV RNAs in HeLa NE since it was absent from all co-
immunoprecipitation assays. This observation correlates with
previous results suggesting that HDAg-S could regulate the
elongation phase of transcription by binding to RNAP II
directly and by displacing the negative elongation factor
(Yamaguchi et al., 2001).
Interestingly, the features and the locations of RNAP II
interaction sites on HDV RNA share structural similarities with
DNA-dependent RNAP binding and/or initiation sites reported
for other related subviral RNAs. E. coli RNAP can bind to and
transcribe from a stem–loop domain derived from the PLMVd
genome (Pelchat et al., 2002; Pelchat and Perreault, 2004). Any
structural alterations that disrupt the overall rod-like conforma-
tion of the RNA template were shown to interfere with de novo
transcription by E. coli RNAP (Pelchat et al., 2002; Pelchat and
Perreault, 2004). Replication of the avocado sunblotch viroid
genome is proposed to initiate within large terminal loops
(Navarro and Flores, 2000). Wheat germ RNAP II was shown to
bind to the large terminal loops of potato spindle tuber viroid
genome (Goodman et al., 1984), and it was recently reported
that potato NE was able to initiate transcription of this viroid
within a terminal stem–loop region of the RNA genome
(Kolonko et al., 2006).
It is now known that the observed structural similarities
between bacterial RNAP and eukaryotic RNAP II involve not
only similarity in overall structural organization, but also
detailed similarity in folding topologies of subunits (Cramer,
2002). In view of the similarities between the RNAPs and the
similarities between the various subviral RNA domains reported
to bind DNA-dependent RNAP, it is tempting to suggest a
common mechanism of RNAP recognition acting on subviral
RNA species. It seems clear that a defined hairpin domain is a
common feature of RNA promoters for these DNA-dependent
RNAPs. Such terminal stem–loop secondary structures with
RNA features specific for each RNAP could thus represent
“universal” RNA binding sites and/or promoter elements for
these DNA-dependent RNAPs.
Materials and methods
Synthesis of HDV-derived RNAs
Polymerase chain reaction (PCR) with Vent polymerase
(New England Biolabs; NEB) was used to amplify DNA
fragments for the synthesis of both genomic and antigenomic
cDNA fragments from a derivative of pBluescriptKS+ (Strata-
gene) containing dimeric HDV genomic cDNA (Kuo et al.,
1988a) flanked by T7 and T3 promoter recognition sites. P11.60
was synthetized as previously described (Pelchat and Perreault,
2004). All R38 and L48 derivatives were transcribed from
double-stranded DNA oligonucleotides possessing a T7 RNA
promoter. DNA products were used for in vitro run off
transcription using T7 RNA polymerase (NEB). HDV dimeric
RNA genomes were similarly synthesized using linearized
plasmid containing a dimer of HDV cDNA as a template for
transcription. After incubation of the transcription reactions at37 °C for 2 h, the reactions were treated with DNase I (Promega)
for an additional 30 min. The RNA products were electrophor-
esed on denaturing 5% or 10% polyacrylamide gels in 1× TBE
buffer (100 mM Tris–borate, pH 8.3, 1 mM EDTA) and 7 M
urea. Following electrophoresis, UV shadowing was used to
detect the RNA bands, which were subsequently excised, eluted
overnight at 4 °C in elution buffer (500 mM ammonium acetate,
0.1% SDS, 20 mM EDTA), precipitated with ethanol, and
resuspended in H2O. Debris and residual urea were removed by
passage through Sephadex G-50 columns (Amersham Pharma-
cia Biotech) and the RNAs were precipitated with ethanol,
resuspended in H2O, quantified by spectrophotometry at
260 nm, and stored at −20 °C. CENTR molecules were
generated using two RNA strands folded together by heat
denaturation at 94 °C and slow renaturation at room temperature
in 40 mM Tris–HCl, pH 8.0/10 mM MgCl2.
Immunoprecipitation of HDV-derived RNAs
The Protein-G Immunoprecipitation Kit (Sigma-Aldrich)
was employed to co-immunoprecipitate HDV RNAs in
accordance with the manufacturer's protocol. Briefly, 5 pmol
of RNAwas 5′-end radiolabeled with [γ-32P]ATP as previously
described (Pelchat et al., 2002) and incubated with 26 μg of
HeLaScribe Nuclear Extract (Promega) in RIP buffer (50 mM
Tris–Cl, pH 7.5, 1% Nonidet P-40 (NP-40), 0.5% sodium
deoxycholate, 0.05% SDS, 1 mM EDTA, 150 mM NaCl;
Niranjanakumari et al., 2002) at 37 °C for 30 min. A 20-fold
excess of poly-A RNA or P11.60 was added to some reactions
as non-specific competitors. A 20-fold excess of cold homo-
logous RNA was used as a specific competitor. Approximately
5 μg of either mouse monoclonal antibody (8WG16; Upstate)
directed against the Rpb1 C-terminal domain (CTD) of RNAP
II or goat anti-mouse IgG (Sigma-Aldrich) was then added to
the reaction mixtures and they were incubated for 2 h at 4 °C on
a rotator. Pre-washed protein-G beads were then added to the
mixtures and incubated overnight as above. Following incuba-
tion, reactions were centrifuged, washed 5 times in RIP buffer,
once with 0.1× RIP buffer, and eluted according to manufac-
turer's protocols in acrylamide loading buffer (Sambrook et al.,
1989). Samples were electrophoresed on denaturing 10%
polyacrylamide gels and the bands were detected by autoradio-
graphy or phosphorimager scanning (Molecular Dynamics).
Ribonucleoprotein immunoprecipitation (RIP) assay
The RIP assay was performed as previously described
(Niranjanakumari et al., 2002) with some modification. HeLa
cells were transfected with 6 μg of pcDNA3-AgS and 10 μg of
dimeric HDV RNA genome of positive polarity using
Lipofectamine TM 2000 Reagent (Invitrogen) in accordance
with manufacturer's protocol. pcDNA3-AgS is a derivative of
pcDNA3 (Stratagene) encoding the small delta antigen under
the control of a CMV promoter (Lazinski and Taylor, 1993).
Formaldehyde (1%) was used to cross-link nucleic acids to
cellular proteins for 5 min at 37 °C. About 106 cells were
harvested by centrifugation, washed twice with ice-cold PBS,
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were resuspended in 2 ml RIP buffer, homogenized by
sonication, and centrifuged at 16,000×g for 30 min at 4 °C.
Immunoprecipitation was performed using the Protein-G Immu-
noprecipitation Kit as above using 500 μl of cell lysate. Samples
were washed 5 times with high-stringency RIP wash buffer
containing 1 M urea (Niranjanakumari et al., 2002), heated to
70 °C for 45min in a solution of 50 mMTris–HCl, pH 7.0, 5 mM
EDTA, 10 mM dithiotriol (DTT), and 1% SDS to reverse the
cross-links, and eluted by centrifugation. The nucleic acids were
extracted by phenol/chloroform, ethanol precipitated, resus-
pended in H2O, and treated with DNAse I (Promega) for 45 min
at 37 °C. After a second RNA extraction with phenol/chloroform
and precipitation with ethanol, the RNAwas resuspended in H2O.
The RNAwas heated for 5 min at 65 °C with 1 pmol of one of the
primers used to generate the R199G cDNA (R199GFW: 5′-
GGAATTCTAATACGACTCACTATAGGG1541ACT-
GCTCGAGGATCTCTTCTCTCCC1565-3′ or R199GREV: 5′-
GGAATTC60ACATCCCCTCTCGGGTGC43-3′; underlined
nucleotides indicate the T7 promoter) in 5 μl of annealing buffer
(50 mMTris–HCl, pH 8.3, 10mMMgCl2, 80mMKCl solution),
and then the mixture quickly snap frozen by immersion in −80 °C
ethanol/dry ice for 2 min. Synthesis was performed by adding 4
units avian myeloblastosis virus reverse transcriptase (Amersham
Pharmacia Biotech) in 5 μl of ice cold annealing buffer containing
8mMDTTand 4mMdNTP to the primer annealed templates, and
then incubating at 42 °C for 30 min. The cDNAwas extracted by
phenol/chloroform, ethanol precipitated, and resuspended in H2O.
PCR amplification using the same primers was composed of 35
cycles of denaturation at 94 °C for 1 min, annealing at 50 °C for
1 min, and extension at 76 °C for 1°min. The primer B-ActinREV
(5′-GGGGTACTTCAGGGTGAGGATGCCTCTCTT-3′) for the
RT reaction and both B-ActinREV and B-ActinFW (5′-ATG-
GATGATGATATCGCCGCGCTCGTCGTC-3′) were used to
perform RT-PCR to generate a small 200 nt cDNA fragment
corresponding to the 5′-end of the β-actin mRNA. Bands were
resolved by 2% agarose gel electrophoresis and visualized under
UV light in the presence of ethidium bromide. Semi-quantitative
RT-PCR was performed as above by ending the PCR amplifica-
tion during the linear phase of amplification. Amplification curves
were carried out by real-time RT-PCR of HDV RNA performed
with an ABI Prism 7300 DNA analyzer (Applied Biosystems) in
the presence of SYBR Green (Invitrogen).
Computer analysis of putative HDV promoter sequences.
All the HDV sequences were taken from the Subviral RNA
Database (http://subviral.med.uottawa.ca/; Rocheleau and Pel-
chat, 2006). Multiple alignments of HDV sequences were
obtained using ClustalW (Thompson et al., 1994). The
alignments were corrected manually to maximize sequence
identities and secondary structural features. Covariation ana-
lyses were performed using BioEdit v7.0.5 (Brown, 1991).
Thermodynamic parameters of RNA promoters were established
for each secondary structure using the RNAeval Software from
the Vienna RNA Structure Software Suite (Hofacker, 2003).
Logos were generated using WebLogo (Crooks et al., 2004).Acknowledgments
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